Regional EuroTimes
Date Posted 04/11/2009
Allergan receives marketing authorisation for new version of Lumigan
Allergan has announced that the Committee for Medicinal Products for Human Use (CHMP) has recommended granting a Marketing Authorisation for a new version of LUMIGAN (bimatoprost ophthalmic solution) 0.01 per cent in the 27 member states of the European Union.
Lumigan 0.01 per cent is being evaluated as first-line therapy for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma and ocular hypertension.
“We are pleased with the decision reached by the committee today to recommend LUMIGAN 0.01 per cent for Marketing Authorisation in Europe, which is an important step in the regulatory review process and one step closer to offering glaucoma patients an additional and enhanced treatment option,” said Mr David Endicott, president, Allergan Ltd., Europe, Africa and the Middle East.
“Clinical studies have shown that the new Lumigan 0.01 per cent formulation provides the same efficacy physicians have come to rely on with the original Lumigan® formulation, with enhanced tolerability resulting in lower treatment-related discontinuation rates,” said Mr Endicott.
eTIMES newsletter
eTIMES is a new bi-monthly newsletter with the latest breaking news from the ESCRS and the world of ophthalmology.
eTIMES is a new bi-monthly newsletter with the latest breaking news from the ESCRS and the world of ophthalmology.
Media Guide 2010
Results from our readership survey plus information about advertising in EuroTimes
Results from our readership survey plus information about advertising in EuroTimes
Podcasts
Eye Contact features interviews with key opinion leaders in the world of ophthalmology
Eye Contact features interviews with key opinion leaders in the world of ophthalmology
Thursday, 09 September 2010
www.eurotimes.org
EuroTimes Breaking News
ESCRS looks forward to 15th Winter Meeting in Istanbul in 2011
Date Posted 08/09/2010 MORE HERE...
Dr Leigh Spielberg wins EuroTimes writing prize for Young Ophthalmologists
Date Posted 08/09/2010 MORE HERE...
Faster lasers and better lens surgery are improving options for higher myopes
Date Posted 07/09/2010 MORE HERE...
All-laser LASIK with Ziemer LDV femtosecond and Allegretto Wave Eye-Q provides highly satisfactory visual outcomes
Date Posted 07/09/2010 MORE HERE...
Removing epithelium with laser speeds healing and reduces pain of corneal surface ablation
Date Posted 07/09/2010 MORE HERE...
Ridley Lecture looks at life and death on the posterior capsule
Date Posted 06/09/2010 MORE HERE...
Industry Breaking News
Rayner launches small-incision IOL injector system
Date Posted 16/08/2010 MORE HERE...
OptiMedica sells retina and glaucoma business to Topcon
Date Posted 16/08/2010 MORE HERE...
Carl Zeiss Meditec announces 20 per cent increase in third quarter revenue
Date Posted 16/08/2010 MORE HERE...
New languages to select from on the Megatron® S4
Date Posted 16/08/2010 MORE HERE...